J Frontier Co., Ltd.
¥1,950+¥1 (+0.05%)
J Frontier Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.92% below the high.
JPX · 3628.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Data Horizon Corporation’s quoted price sits in the upper half of its reported 52-week range, 6.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Data Horizon Corporation’s forward annual dividend is ¥7 per share, paid annual. The forward yield is 0.95% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Data Horizon Corporation’s next earnings report is currently expected on Nov 5, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Data Horizon Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Data Horizon Corporation offers specialized health data support solutions to insurance providers across Japan. The company develops and supplies medical information services, encompassing health-relevant data and notifications about generic drugs, alongside a comprehensive system designed to support health-related businesses. Founded in 1981, its headquarters are situated in Hiroshima, Japan. Data Horizon Corporation operates as a subsidiary of DeNA Co., Ltd.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,950+¥1 (+0.05%)
J Frontier Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.92% below the high.
¥585-¥2 (-0.34%)
GENOVA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.33% below the high.
¥3,475-¥25 (-0.71%)
Yamashita Health Care Holdings,Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
¥766+¥2 (+0.26%)
Mental Health Technologies Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.74% below the high.
¥27-¥1 (-3.57%)
Solasia Pharma K.K.’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
¥800-¥1 (-0.12%)
ADR120S, Inc.’s quoted price sits in the lower half of its reported 52-week range, 10.11% below the high.
¥277-¥1 (-0.36%)
Softmax Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 33.41% below the high.
¥243-¥3 (-1.22%)
Tsubota Laboratory Incorporated’s quoted price sits in the lower half of its reported 52-week range, 49.16% below the high.